Latest news

5 Quick Questions with PK Dutta

30 June, 2022

P.K. DUTTA, Ph.D., SVP Sales Nanologica AB Who are you? I am a Molecular Biologist by training. I have spent most of my career dealing with large scale silica based industrial purification of peptides and small molecules. Before joining Nanologica, I held leadership and strategic roles for global silica brands like Waters, Kromasil and YMC. I am very honored to be part of the Nanologica Business Development Team, establishing a more significant presence in the

Nanologica takes out loan of MSEK 20 within agreed credit facility

27 June, 2022

Nanologica AB (publ) has taken out a loan of MSEK 20 from the credit facility agreed in January with Flerie Invest AB. The loan is taken out to cover the company’s temporary financial needs pending expected cash flows from the operations in preparative chromatography. After this loan, the credit facility has been used in full. Parts of the proceeds will be used to repay a loan from a private financier of MSEK 10 that expires

Nanologica upptar lån om 20 MSEK inom avtalad kreditfacilitet

27 June, 2022

Nanologica AB (publ) har upptagit ett lån om 20 MSEK ur den kreditfacilitet som i januari avtalades med Flerie Invest AB. Lånet upptas i syfte att överbrygga bolagets tillfälliga finansiella behov i väntan på förväntade kassaflöden från verksamheten inom preparativ kromatografi. Efter lånet har hela kreditfaciliteten nyttjats. Delar av likviden kommer att användas för att betala tillbaka ett lån från en privat finansiär om 10 MSEK som löper ut den 1 juli 2022 och som

Analytica in Munich

14 June, 2022

Next week from June 21 to 24, Nanologica will be at Analytica in Munich! Analytica is the leading industry event for analytics, laboratory technology and biotechnology. With 1,200 exhibitors, 36,000 visitors and 55,000 square meters of exhibition space, Analytica is the largest trade fair for analysis, laboratory technology and biotechnology in the world. As the industry’s definitive forum, Analytica gives visitors a comprehensive market overview and information about the latest developments in laboratory technology, analysis

Bulletin from the Annual General Meeting of Nanologica AB (publ)

2 June, 2022

Today June 2nd, 2022, Nanologica AB (publ) held its annual general meeting for the financial year 2021, where the following resolutions were passed. Adoption of income statement and balance sheet for the financial year 2021 and disposition of result The annual general meeting adopted the income statement and balance sheet for the company and for the group in accordance with the presented accounting documents, and resolved, in accordance with the board’s proposal, that the accumulated

Kommuniké från årsstämma i Nanologica AB (publ)

2 June, 2022

Nanologica AB (publ) höll idag den 2 juni 2022 sin årsstämma för verksamhetsåret 2021, varvid följande beslut fattades. Fastställande av resultat- och balansräkning, disponering av resultat Årsstämman fastställde resultaträkningen och balansräkningen för bolaget och för koncernen enligt framlagda redovisningshandlingar samt beslutade, i enlighet med styrelsens förslag, att ansamlad förlust om -46 224 712 kronor överförs i ny räkning. Beslutet innebär således att ingen utdelning lämnas för räkenskapsåret 2021. Ansvarsfrihet Årsstämman beviljade styrelseledamöterna och verkställande

About us

Nanologica is a Swedish life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company’s mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments. The company is headquartered in Södertälje and Nanologica’s share (NICA) is listed for trading on Nasdaq Stockholm Main Market.

Categories

News archive

5 Quick Questions with PK Dutta

Nanologica takes out loan of MSEK 20 within agreed credit facility

Nanologica upptar lån om 20 MSEK inom avtalad kreditfacilitet

Analytica in Munich

Bulletin from the Annual General Meeting of Nanologica AB (publ)

Kommuniké från årsstämma i Nanologica AB (publ)